Skip to content

Effectiveness of Interventions to Teach Respiratory Inhaler Technique (E-TRaIN)

Effectiveness of Interventions to Teach Respiratory Inhaler techNique (E-TRaIN)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01426581
Acronym
E-TRaIN
Enrollment
120
Registered
2011-08-31
Start date
2011-08-31
Completion date
2013-02-28
Last updated
2019-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Chronic Obstructive Pulmonary Disease (COPD)

Keywords

Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Disease, Chronic Obstructive, Lung Disease, Obstructive, Self-management, Health Literacy

Brief summary

The purpose of this study is to evaluate the relative effectiveness of two different ways to teach subjects while hospitalized how to use respiratory inhalers and to follow-up after discharge home from the hospital to determine durability of the education. Teach-to-Goal (TTG) education employs instruction followed by patient teach-back, then repeated cycles of learning and assessment until a skill is mastered. By contrast, Brief Intervention (BI) education only consists of providing the patient with verbal and written instruction. The investigators hypothesize that hospital-based TTG compared to BI increases a patient's ability to retain instructions on respiratory inhaler technique. The investigators will test this hypothesis separately for the MDI and Diskus® devices after discharge.

Detailed description

Respiratory inhalers are often used incorrectly by patients with obstructive lung disorders (including patients hospitalized with exacerbations of asthma or chronic obstructive pulmonary disease (COPD). As the mainstay of bronchodilator and anti-inflammatory therapy in patients with OLD, the implication of this difficulty with self-management is that patients are at risk for under-treatment and worse health outcomes. Several factors are thought to contribute to poor self-management skills, particularly inadequate patient education at healthcare encounters and inadequate patient health literacy. However, the most effective strategy to instruct patients about respiratory inhaler use in hospital settings is unclear, particularly in populations enriched with inadequate health literacy. Therefore, the overall goal of this study is to evaluate the relative effectiveness of two hospital-based educational interventions: Teach-To-Goal (TTG, iterative cycles of demonstration-based education and assessment) versus Brief Intervention (BI, one-time set of verbal instructions) on the durability of instructions provided in the hospital and its effect on clinical outcomes (e.g., respiratory events and/or death), post hospital discharge. The investigators also plan to evaluate whether the relative effectiveness of TTG vs. BI varies by level of health literacy. The objectives of this proposal are to conduct a study in adults hospitalized with asthma/COPD to 1) to evaluate the relative effectiveness of hospital-based TTG versus BI on patients' ability to retain instruction about the correct use of MDI and Diskus® devices after discharge home and 2) To determine the relative effectiveness of TTG compared to BI for patients with less-than-adequate health literacy compared to those with adequate health literacy. These data will inform the development of a larger, multi-center clinical trial.

Interventions

BEHAVIORALTeach-To-Goal

Participants observe a demonstration on the use of each inhaler, with corresponding verbal step-by-step instructions (demonstration, verbal instruction), then participants 'teachback or re-demonstrate the steps; cycles are repeated are read step-by-step instructions (verbal instructions) for each respective inhaler (Metered Dose Inhaler +/- Diskus), and receive a copy of these instructions with images depicting the steps (written instructions)

BEHAVIORALBrief Intervention

Participants are read step-by-step instructions (verbal instructions) for each respective inhaler (Metered Dose Inhaler +/- Diskus), and receive a copy of these instructions with images depicting the steps (written instructions)

Sponsors

University of Chicago
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years and older * Admitting diagnosis of asthma or COPD * Physician- diagnosed asthma, asthma/COPD, or COPD. We will enroll patients even if the primary reason for admission is not asthma or COPD (e.g., patients admitted for heart failure, but with a physician diagnosis of COPD are eligible) * Patient will be discharged home on a Metered Dose Inhaler (MDI; e.g., albuterol)

Exclusion criteria

* Currently in an intensive care unit * Physician declines to provide consent * Patient unable to provide consent (e.g., history of cognitive impairment, unable to understand English) or declines to provide consent * Previous participant in this study

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Participants With MDI Misuse From Baseline to 30 Days Post-Discharge1 monthTo evaluate the relative effectiveness of hospital-based TTG versus BI on patients' ability to retain instruction about the correct use of MDI Devices one month after discharge home.

Secondary

MeasureTime frameDescription
Role of Health Literacy - Number of Less-Than-Adequate Health Literacy Participants With 30 Days Post Discharge Acute-Care Events1 monthTo determine the relative effectiveness of TTG compared to BI for patients with less-than-adequate health literacy using self-reported acute-care events 30 days post discharge. To measure less-than-adequate health literacy, the investigators administered the Short Test of Functional Health Literacy in Adults, a validated tool to assess whether a participant has adequate, marginal, or inadequate health literacy. Less-than-adequate included marginal and inadequate health literacy.
Number of Participants With Self-Efficacy1 monthThis is a self-reported measure of how confident a participant is on how well they use their metered dose inhaler.
Symptom Control1 monthSymptom control will be assessed using interviewer-administered surveys. Using the Borg Dyspnea Scale, a validated Scale from 0 - 20 where 20 is maximal dyspnea, we took the difference between the the 30 day follow-up self reported shortness of breath from baseline to see if there was improvement in symptom control.
Number of Participants With Acute Care Events 30 Days Post Discharge1 monthExacerbation/acute care events within one month of hospital discharge

Countries

United States

Participant flow

Recruitment details

Participants were randomized into TTG or BI between September 2011 and February 2013. Of the 120 participants, 100 were enrolled at hospital #1 and 20 were enrolled from hospital #2.

Participants by arm

ArmCount
Teach To Goal
Intervention: Teach to Goal Teach-To-Goal: Participants observe a demonstration on the use of each inhaler, with corresponding verbal step-by-step instructions (demonstration, verbal instruction), then participants 'teachback or re-demonstrate the steps; cycles are repeated are read step-by-step instructions (verbal instructions) for each respective inhaler (Metered Dose Inhaler +/- Diskus), and receive a copy of these instructions with images depicting the steps (written instructions)
62
Brief Intervention
Brief Intervention Brief Intervention: Participants are read step-by-step instructions (verbal instructions) for each respective inhaler (Metered Dose Inhaler +/- Diskus), and receive a copy of these instructions with images depicting the steps (written instructions)
58
Total120

Baseline characteristics

CharacteristicTeach To GoalBrief InterventionTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
8 Participants7 Participants15 Participants
Age, Categorical
Between 18 and 65 years
54 Participants51 Participants105 Participants
Sex: Female, Male
Female
47 Participants41 Participants88 Participants
Sex: Female, Male
Male
15 Participants17 Participants32 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 620 / 58
serious
Total, serious adverse events
0 / 620 / 58

Outcome results

Primary

Percentage of Participants With MDI Misuse From Baseline to 30 Days Post-Discharge

To evaluate the relative effectiveness of hospital-based TTG versus BI on patients' ability to retain instruction about the correct use of MDI Devices one month after discharge home.

Time frame: 1 month

ArmMeasureGroupValue (NUMBER)
Teach to GoalPercentage of Participants With MDI Misuse From Baseline to 30 Days Post-DischargeMisuse at Baseline92 percentage
Teach to GoalPercentage of Participants With MDI Misuse From Baseline to 30 Days Post-DischargeMisuse at 30 days post-discharge11 percentage
Brief InterventionPercentage of Participants With MDI Misuse From Baseline to 30 Days Post-DischargeMisuse at Baseline84 percentage
Brief InterventionPercentage of Participants With MDI Misuse From Baseline to 30 Days Post-DischargeMisuse at 30 days post-discharge60 percentage
Secondary

Number of Participants With Acute Care Events 30 Days Post Discharge

Exacerbation/acute care events within one month of hospital discharge

Time frame: 1 month

Population: The discrepancy between the number of participants analyzed in each group and the number of participants in each arm total is due to lost to follow-up. In the Teach to Goal arm, 8 participants were lost to follow up and 5 participants were lost to follow up in the Brief Intervention arm.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Teach to GoalNumber of Participants With Acute Care Events 30 Days Post Discharge9 Participants
Brief InterventionNumber of Participants With Acute Care Events 30 Days Post Discharge19 Participants
Secondary

Number of Participants With Self-Efficacy

This is a self-reported measure of how confident a participant is on how well they use their metered dose inhaler.

Time frame: 1 month

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Teach to GoalNumber of Participants With Self-Efficacy49 Participants
Brief InterventionNumber of Participants With Self-Efficacy38 Participants
Secondary

Role of Health Literacy - Number of Less-Than-Adequate Health Literacy Participants With 30 Days Post Discharge Acute-Care Events

To determine the relative effectiveness of TTG compared to BI for patients with less-than-adequate health literacy using self-reported acute-care events 30 days post discharge. To measure less-than-adequate health literacy, the investigators administered the Short Test of Functional Health Literacy in Adults, a validated tool to assess whether a participant has adequate, marginal, or inadequate health literacy. Less-than-adequate included marginal and inadequate health literacy.

Time frame: 1 month

Population: Out of 120 participants, 23 were screened to have less-than-adequate health literacy.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Teach to GoalRole of Health Literacy - Number of Less-Than-Adequate Health Literacy Participants With 30 Days Post Discharge Acute-Care Events2 Participants
Brief InterventionRole of Health Literacy - Number of Less-Than-Adequate Health Literacy Participants With 30 Days Post Discharge Acute-Care Events7 Participants
Secondary

Symptom Control

Symptom control will be assessed using interviewer-administered surveys. Using the Borg Dyspnea Scale, a validated Scale from 0 - 20 where 20 is maximal dyspnea, we took the difference between the the 30 day follow-up self reported shortness of breath from baseline to see if there was improvement in symptom control.

Time frame: 1 month

Population: The discrepancy from the number of participants in each group and the number of participants analyzed is due to missing data values due to lose to follow-up for the 30-day post discharge visit. 8 participants did not have values in the Teach To Goal group and 5 did not for the Brief Intervention group.

ArmMeasureValue (MEAN)Dispersion
Teach to GoalSymptom Control-1.69 units on a scaleStandard Deviation 2.75
Brief InterventionSymptom Control-1.43 units on a scaleStandard Deviation 2.59

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026